subgroup of
drug)
→
CapableOf
→
receive approval
| Typicality: | 0.324 |
| Saliency: | 0.379 |
| from an fda advisory panel | 3 | other |
| in order | 2 | manner |
| new drug → receive → approval | 4 |
| new drug → gets → approved | 4 |
| new drug → won → approval | 3 |
| new drug → received → approval | 3 |
| negative | neutral | positive |
| 0.050 | 0.461 | 0.489 |
| Raw frequency | 14 |
| Normalized frequency | 0.379 |
| Modifier score | 0.500 |
| Perplexity | 361.080 |